L&S RESEARCH CORP.'s $1.45 MILLION SETTLEMENT WITH FTC
This article was originally published in The Tan Sheet
Executive Summary
L&S RESEARCH CORP.'s $1.45 MILLION SETTLEMENT WITH FTC over claims made for its Cybergenics product line includes a provision that the company will no longer promote chromium picolinate for fat-burning. The consent order requires L&S to "cease and desist from representing" that "chromium picolinate, in any [weight-loss] product or used in conjunction with any [weight-loss] program, builds muscle, reduces fat, or lowers cholesterol."